2015
DOI: 10.18410/jebmh/2015/534
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and Investigational Study of Diabetic Ketoacidosis

Abstract: BACKGROUND AND OBJECTIVES: To compare the clinical features and biochemical profile in DKA. To assess the response in the patients with standard treatment of DKA. Clinical descriptions of polyuric states resembling diabetes mellitus have been described in the Ebers papyrus of Egypt in 15th century BC. 1,2 Ayurvedic literature from the times of Charaka and Sushrutha, the ancient Indian physicians identified two forms of "MadhuMeha" (Honeyed Urine) in 400 BC. 3 John Rolo of England in 1797 was one of 1st who coi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 4 publications
0
0
0
Order By: Relevance
“…Jeannette Goguen and Jeremy Gilbert have realized that diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are diabetes emergencies with overlapping features that require treatment and monitoring for multiple metabolic abnormalities and vigilance for complications (Goguen & Gilbert, 2018). Y. V. Lakshmi Narasimham and his coauthors have compared the clinical features and biochemical profile in DKA to assess the response in the patients with standard treatment of DKA (Narasimham et al, 2015). Haradhan Kumar Mohajan and Devajit Mohajan have discussed the aspects of body fitness in different articles for the development of health of diabetes patients and older citizens (Mohajan & Mohajan, 2023a-i).…”
Section: Literature Reviewmentioning
confidence: 99%
See 1 more Smart Citation
“…Jeannette Goguen and Jeremy Gilbert have realized that diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are diabetes emergencies with overlapping features that require treatment and monitoring for multiple metabolic abnormalities and vigilance for complications (Goguen & Gilbert, 2018). Y. V. Lakshmi Narasimham and his coauthors have compared the clinical features and biochemical profile in DKA to assess the response in the patients with standard treatment of DKA (Narasimham et al, 2015). Haradhan Kumar Mohajan and Devajit Mohajan have discussed the aspects of body fitness in different articles for the development of health of diabetes patients and older citizens (Mohajan & Mohajan, 2023a-i).…”
Section: Literature Reviewmentioning
confidence: 99%
“…Lethargy and somnolence are symptoms of more severe decompensation (Edge et al, 2001;Wolfsdorf et al, 2018). The patient may present with wide range of manifestations like ketosis, ketoacidosis, ketoacidosis pre-coma and coma (Narasimham et al, 2015). DKA occurs in patients with type 1 diabetes (T1D) (70% to 90%) and is less common in those with type 2 diabetes (T2D) (10% to 30%), and mortality rate in diabetic ketoacidosis is 4% (Barski et al, 2013).…”
Section: Diabetic Ketoacidosismentioning
confidence: 99%
“…Risk factors for DKA are insulin omission, infection, myocardial infarction (MI), abdominal crisis, trauma, and possibly continuous subcutaneous insulin infusion (CSII) therapy, thyrotoxicosis, cocaine, atypical antipsychotics, and possibly interferon (Hamblin et al, 1989;Wolfsdorf et al, 2018). The patient may present with wide range of manifestations like ketosis, ketoacidosis, ketoacidosis pre-coma and coma (Narasimham et al, 2015). Laboratory and bedside biochemical measurements for DKA, such as capillary blood glucose, urine or blood ketones, serum potassium, sodium, phosphate, and venous pH should be evaluated regularly (Eledrisi et al, 2006).…”
Section: Risk Factors and Treatment Of Dkamentioning
confidence: 99%